Healthpeak Properties (NYSE:DOC) PT Raised to $23.00 at Scotiabank

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price target upped by investment analysts at Scotiabank from $22.00 to $23.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a "sector outperform" rating on the real estate investment trust's stock. Scotiabank's price objective suggests a potential upside of 15.17% from the company's current price.

Several other equities analysts also recently commented on the stock. Mizuho reiterated a "buy" rating and set a $22.00 price target on shares of Healthpeak Properties in a report on Monday, April 22nd. BNP Paribas upgraded Healthpeak Properties from a "neutral" rating to an "outperform" rating and increased their price target for the stock from $19.00 to $21.00 in a report on Friday, April 26th. Argus raised Healthpeak Properties to a "strong-buy" rating in a research report on Thursday, May 9th. Royal Bank of Canada increased their target price on Healthpeak Properties from $21.00 to $22.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 10th. Finally, JPMorgan Chase & Co. upped their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a "neutral" rating in a report on Thursday. One analyst has rated the stock with a sell rating, six have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $19.08.

Healthpeak Properties Trading Down 1.4 %

NYSE DOC traded down $0.28 on Thursday, hitting $19.97. 5,175,764 shares of the stock were exchanged, compared to its average volume of 6,960,159. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.69 and a current ratio of 0.69. Healthpeak Properties has a 52-week low of $15.24 and a 52-week high of $22.38. The firm has a market capitalization of $14.05 billion, a P/E ratio of 57.06, a P/E/G ratio of 1.92 and a beta of 1.01. The stock has a fifty day moving average price of $18.40 and a two-hundred day moving average price of $14.47.

Institutional Investors Weigh In On Healthpeak Properties

Several institutional investors have recently bought and sold shares of DOC. Charles Schwab Investment Management Inc. boosted its position in shares of Healthpeak Properties by 6.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,943,465 shares of the real estate investment trust's stock worth $52,488,000 after purchasing an additional 239,972 shares in the last quarter. American Century Companies Inc. lifted its position in Healthpeak Properties by 2.0% during the 3rd quarter. American Century Companies Inc. now owns 3,364,875 shares of the real estate investment trust's stock worth $41,018,000 after acquiring an additional 65,814 shares during the period. Norges Bank purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $34,883,000. Victory Capital Management Inc. increased its holdings in shares of Healthpeak Properties by 4.0% in the fourth quarter. Victory Capital Management Inc. now owns 2,270,712 shares of the real estate investment trust's stock valued at $30,223,000 after purchasing an additional 87,506 shares during the period. Finally, California Public Employees Retirement System raised its stake in shares of Healthpeak Properties by 10.1% in the third quarter. California Public Employees Retirement System now owns 1,599,447 shares of the real estate investment trust's stock worth $19,497,000 after purchasing an additional 146,993 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.